Who we are

Apexus works with more than 27,000 health care providers across the United States to lower their costs for purchasing outpatient pharmaceutical products, allowing them to stretch their resources to serve more low-income and uninsured patients. As the exclusive contractor for the 340B Drug Pricing Program, managed by the Health Resources and Service Administration (HRSA), Apexus negotiates significant discounts for branded and generic pharmaceuticals while working with providers to help them comply with 340B regulations and guidance. Apexus works closely with HRSA's Office of Pharmacy Affairs to improve the integrity of the 340B program.

How Apexus Can Help You:



Negotiating with hundreds of pharmaceutical companies to obtain savings on thousands of products and services.



Running the 340B UniversityTM, a HRSA-endorsed training program to assist stakeholders in remaining fully compliant with 340B rules and regulations.


Distribution Network

Providing a national network of traditional and specialty distributors to enable 340B-priced medications to reach participating hospitals and clinics.

Apexus Answers

Apexus Answers

Managing Apexus Answers, the national 340B call center, for all stakeholders.


Frequently Asked Questions (FAQs), or the most often asked inquires, are here for your convenience. Have a 340B question? It may have already been answered. View Apexus' FAQ page to find out.

340B Tools

Industry experts collaborated to create various tools and resources to assist entities in promoting 340B compliance and providing practical information about 340B program fundamentals.

Latest Events

Apexus keeps an up to date compilation of events relevant to 340B, including background information and registration links. This includes links to all 340B University sessions.

The Apexus Compass

My Apexus Experience—the 340B Rotation

Sonia Tadjalli, PharmD

Early in my PGY2 health-system pharmacy administration residency, I recognized the importance of the 340B program to our organization and patients. I started to get involved in various projects and operational processes that involved 340B, and continually sought opportunities to advance my knowledge on the subject matter. I was fortunate to have participated in an Apexus site visit while at Novant Health, where I experienced firsthand the great value and expertise of the Apexus team. When I discovered the four-week rotation with Apexus, I was eager to pursue this opportunity.

During my rotation with Apexus, I learned even more than I had initially anticipated. I was exposed to a wealth of information and became involved with various projects that not only greatly benefited myself, but allowed me to contribute to the Apexus team as well. I was able to collaborate with senior leadership to contribute to various organizational strategic imperatives in education and compliance support, operations, and marketing. For example, I analyzed and summarized HRSA audit information, which provided me with great insight on trends and considerations for audit preparedness. I was able to review Apexus 340B University OnDemand™ modules prior to their release and provided feedback for enhancement. I also networked with various entities nationwide to research central fill models and discuss considerations for ensuring 340B-compliant operations.

Additionally, I was able to work in the Apexus Answers call center, where I provided responses to inquiries that aligned with HRSA policy and guidance to promote program integrity for 340B Prime Vendor Program participants and stakeholders. The greatest skill I learned from working in the call center was learning how to navigate available resources to find the information requested. My last week of the Apexus rotation was spent back at Novant Health, where I was able to apply much of the information I had learned. I was able to work with our 340B team to perform thorough assessments of our program, using Apexus tools, to ensure compliant operations. This part of the rotation enabled me to apply the knowledge I gained during my rotation, and allowed me to immediately bring value to my organization.

In addition to all the 340B knowledge gained, one of the aspects of the Apexus rotation that I valued the most was the opportunity to have one-on-one meetings with the Apexus leadership team. These sessions provided me with invaluable leadership pearls that I will carry with me throughout my career. The fact that I was able to work with individuals who have several years of industry experience, with various backgrounds, allowed me to walk away with knowledge that is not readily available in residency programs.

The Apexus rotation exposes residents to a nontraditional aspect of pharmacy practice that has a great impact on many entities nationwide. Having greater in-depth knowledge of the 340B program is a value-added skill that elevates the level of pharmacy practice across the profession. This is a unique rotation for residents; regardless of the area of practice a resident chooses to pursue, the skills and network gained from a rotation with Apexus creates career-advancing opportunities. I highly recommend and encourage PGY2 health-system pharmacy administration residents to take advantage of this program.

Taking the Chains Off 340B
November 5, 2015

ISMP October Newsletter
October 30, 2015

Orphan Drug Ruling
October 15, 2015

ISMP September Newsletter
September 30, 2015

ACCP and RI Award Grant
September 28, 2015

A New Place on the Continuum
September 23, 2015

ISMP August Newsletter
August 31, 2015

ISMP July Newsletter
July 30, 2015

ISMP June Newsletter
July 6, 2015

340B University December 6
December 6, 2015

CBI Reimbursement and Contracting
February 4, 2016
Wyndham Historic District, Philadelphia, PA

340B Coalition Winter Conference
February 17, 2016
Hotel Del Coronado, San Diego, CA

APhA 2016 Annual Meeting Exposition
March 4, 2016
Baltimore Convention Center, Baltimore, MD

ACHE Congress on Healthcare Leadership
March 14, 2016
Hyatt Regency Chicago, Chicago, IL

March 16, 2016
Marriott Wardman Park Hotel, Washington, DC